Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in INTELLIA THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 283,958 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $3.6M as of 2026-Q1. The position was increased (+18.7% shares). NTLA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.6M
Current Shares
283,958
Total Value Change
-$7.8M
Total Shares Change
-228,351
Other major holders of NTLA: BNP PARIBAS FINANCIAL MARKETS, BANQUE PICTET & CIE SA
Increased |
| 283,958 |
+18.7% |
| $3.6M |
| 0.0% |
| $13.60 |
31 |
| 2025-Q4 | Decreased | 239,247 | -0.8% | $2.2M | 0.0% | $9.06 | 0 |
| 2025-Q3 | Decreased | 241,282 | -62.2% | $4.2M | 0.0% | $16.92 | 0 |
| 2025-Q2 | Increased | 637,861 | +22.3% | $6M | 0.0% | $9.56 | 33 |
| 2025-Q1 | Increased | 521,706 | +8.0% | $3.7M | 0.0% | $8.07 | 29 |
| 2024-Q4 | Increased | 483,185 | +5.0% | $5.6M | 0.0% | $11.41 | 28 |
| 2024-Q3 | Decreased | 460,012 | -10.2% | $9.5M | 0.0% | $21.00 | 0 |
| 2024-Q2 | Increased | 512,309 | +35.0% | $11.5M | 0.0% | $22.38 | 36 |